ZJC-16435-58856 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-25
Dose 1 — Pfizer-BioNTech
2021-05-26
Registered in v-safe
2021-05-26
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Presyncope — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Dizziness, near syncope

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-27
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-28
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Abdominal pain

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-31
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Injection site bruising, Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Free text: Dizziness, unilateral swollen lymph node near injection site, unilateral sore throat on same side as injection site (likely from lymph node swelling), mild bruising at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-15
Dose 2 — Pfizer-BioNTech
2021-06-16
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-17
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Injection site lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Free text: Dizziness, swollen lymph node near site of injection, unilateral sore throat near lymph node/on side of injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-29
Survey response — day 42, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good

Free text: Pain in left pelvic region similar to but worse than past pain associated with ovarian cysts

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-06-15
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-25	Pfizer-BioNTech
2	2021-06-15	Pfizer-BioNTech

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-26

Systemic reaction (other): Dizziness, near syncope

2021-05-27

Systemic reaction (other): Dizziness

2021-05-28

Systemic reaction (other): Dizziness

2021-05-31

Systemic reaction (other): Dizziness, unilateral swollen lymph node near injection site, unilateral sore throat on same side as injection site (likely from lymph node swelling), mild bruising at injection site

Release 9 — days 1–6 daily, dose 2

2021-06-16

Systemic reaction (other): Dizziness

2021-06-17

Systemic reaction (other): Dizziness, swollen lymph node near site of injection, unilateral sore throat near lymph node/on side of injection

Release 9 — day 42, dose 2

2021-07-29

Symptoms: Pain in left pelvic region similar to but worse than past pain associated with ovarian cysts

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	✓	·	✓
SD	Pre-existing disease	✓	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Injection site bruising	✓	✓	✓
SRO	Injection site lymphadenopathy	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Presyncope	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release